Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter
Provided By PR Newswire
Last update: Jun 11, 2024
-- Issuance of U.S. Patent No. 11,992,472 Further Strengthens Evofem's Intellectual Patent Portfolio --
-- Newly issued patent is Evofem's fifth covering Hormone-Free "In the Moment" Contraceptive Phexxi in the United States --
Read more at prnewswire.com0.2151
-0.08 (-28.06%)
Find more stocks in the Stock Screener
ADTX Latest News and Analysis
